Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.
Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells ...
During fiscal year 2024, it reported $466 million in licensing revenue. The Duke University Human Vaccine Institute was awarded $7 million from the federal health agencies to conduct clinical trials ...
Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...
The director of NIAID is appointed by the head of the NIH, who must be approved by the Senate. Directors have broad ...
[iStockphoto] In an exciting development, researchers at the Duke Human Vaccine Institute have made a major stride toward an effective HIV vaccine. Their experimental vaccine candidate was able to ...
Fran Lund, Ph.D., an internationally recognized scientist who has uncovered crucial additional roles for the immune system’s ...
Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest ...